157 related articles for article (PubMed ID: 15627437)
1. The effect of a novel, dual function histamine H1 receptor antagonist/5-lipoxygenase enzyme inhibitor on in vivo dermal inflammation and extravasation.
Giannaras A; Selig W; Ellis J; Hullinger T
Eur J Pharmacol; 2005 Jan; 506(3):265-71. PubMed ID: 15627437
[TBL] [Abstract][Full Text] [Related]
2. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms.
Roumestan C; Henriquet C; Gougat C; Michel A; Bichon F; Portet K; Jaffuel D; Mathieu M
Clin Exp Allergy; 2008 Jun; 38(6):947-56. PubMed ID: 18498541
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation.
Lorrain DS; Bain G; Correa LD; Chapman C; Broadhead AR; Santini AM; Prodanovich P; Darlington JV; Hutchinson JH; King C; Lee C; Baccei C; Li Y; Arruda JM; Evans JF
J Pharmacol Exp Ther; 2009 Dec; 331(3):1042-50. PubMed ID: 19749079
[TBL] [Abstract][Full Text] [Related]
4. U46619 (a thromboxane A2 mimetic) induces airflow obstruction and airway plasma extravasation in the guinea pig: the role of histamine, cyclooxygenase metabolites, leukotrienes and PAF.
Kawikova I; Arakawa H; Skoogh BE; Löfdahl CG; Lötvall J
J Pharmacol Exp Ther; 1996 Jul; 278(1):268-76. PubMed ID: 8764360
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative.
Fukuda S; Midoro K; Yamasaki M; Gyoten M; Kawano Y; Fukui H; Ashida Y; Nagaya H
Inflamm Res; 2003 May; 52(5):206-14. PubMed ID: 12813625
[TBL] [Abstract][Full Text] [Related]
6. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat.
Pichat P; Angel I; Arbilla S
Arzneimittelforschung; 1998 Feb; 48(2):173-8. PubMed ID: 9541729
[TBL] [Abstract][Full Text] [Related]
8. Effect of tecastemizole on pulmonary and cutaneous allergic inflammatory responses.
Lever R; Hefni A; Moffatt JD; Paul W; Page CP
Clin Exp Allergy; 2007 Jun; 37(6):909-17. PubMed ID: 17517105
[TBL] [Abstract][Full Text] [Related]
9. Phorbol ester-induced dermal inflammation in mice: evaluation of inhibitors of 5-lipoxygenase and antagonists of leukotriene B4 receptor.
Rao TS; Yu SS; Djuric SW; Isakson PC
J Lipid Mediat Cell Signal; 1994 Sep; 10(3):213-28. PubMed ID: 7812673
[TBL] [Abstract][Full Text] [Related]
10. Novel dual acting molecules possessing 5-lipoxygenase enzyme inhibition and histamine H(1) receptor antagonist properties.
Scannell RT; Arrington MP; Bayless L; Cai X; Eckman JB; Eckert M; Ene DG; Ellis JL; Hussoin S; Latham GM; Lewis TA; Libertine L; Nicolas J; Selig WM; Schwartz CE; Wels BF; Wypij DM; Young MA; Zou D
Inflamm Res; 2004 Mar; 53 Suppl 1():S33-4. PubMed ID: 15054606
[No Abstract] [Full Text] [Related]
11. Role of H1 receptors in histamine-mediated up-regulation of STAT4 phosphorylation.
Liu Z; Kharmate G; Patterson E; Khan MM
Int Immunopharmacol; 2006 Mar; 6(3):485-93. PubMed ID: 16428084
[TBL] [Abstract][Full Text] [Related]
12. 5-lipoxygenase inhibitors with histamine H(1) receptor antagonist activity.
Lewis TA; Bayless L; Eckman JB; Ellis JL; Grewal G; Libertine L; Marie Nicolas J; Scannell RT; Wels BF; Wenberg K; Wypij DM
Bioorg Med Chem Lett; 2004 May; 14(9):2265-8. PubMed ID: 15081022
[TBL] [Abstract][Full Text] [Related]
13. A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.
Suzuki K; Morokata T; Morihira K; Sato I; Takizawa S; Kaneko M; Takahashi K; Shimizu Y
Eur J Pharmacol; 2007 Jun; 563(1-3):224-32. PubMed ID: 17336292
[TBL] [Abstract][Full Text] [Related]
14. Histamine H(4) receptor antagonist ameliorates chronic allergic contact dermatitis induced by repeated challenge.
Seike M; Furuya K; Omura M; Hamada-Watanabe K; Matsushita A; Ohtsu H
Allergy; 2010 Mar; 65(3):319-26. PubMed ID: 19886918
[TBL] [Abstract][Full Text] [Related]
15. Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice.
Ui H; Andoh T; Lee JB; Nojima H; Kuraishi Y
Eur J Pharmacol; 2006 Jan; 530(1-2):172-8. PubMed ID: 16359660
[TBL] [Abstract][Full Text] [Related]
16. AWD 12-281, a highly selective phosphodiesterase 4 inhibitor, is effective in the prevention and treatment of inflammatory reactions in a model of allergic dermatitis.
Bäumer W; Gorr G; Hoppmann J; Ehinger AM; Rundfeldt C; Kietzmann M
J Pharm Pharmacol; 2003 Aug; 55(8):1107-14. PubMed ID: 12956900
[TBL] [Abstract][Full Text] [Related]
17. Role of 5-lipoxygenase products in the local accumulation of neutrophils in dermal inflammation in the rabbit.
Marleau S; Fruteau de Laclos B; Sanchez AB; Poubelle PE; Borgeat P
J Immunol; 1999 Sep; 163(6):3449-58. PubMed ID: 10477617
[TBL] [Abstract][Full Text] [Related]
18. Middle ear mucosal inflammation: an in vivo model.
Chan KH; Swarts JD; Tan L
Laryngoscope; 1994 Aug; 104(8 Pt 1):970-80. PubMed ID: 8052083
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic modulation of delayed-type hypersensitivity in mice.
Yamada N; Sugasawa K
Arzneimittelforschung; 1996 Sep; 46(9):884-6. PubMed ID: 8876937
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of allergic dermal inflammation by the novel imidazopyridazine derivative TAK-427 in a guinea pig experimental model of eczema.
Fukuda S; Midoro K; Kamei T; Gyoten M; Kawano Y; Ashida Y; Nagaya H
J Pharmacol Exp Ther; 2002 Dec; 303(3):1283-90. PubMed ID: 12438553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
